Table 3.
| ||||
Analysis by ITT (n = 200) | MOCK (n = 106) | Control (n = 94) | Relative risk (95% CI) | P-value |
Clinical pregnancy rate | 43/106 (40.56) | 38/94 (40.42) | 1.0035 (0.7167-1.4051) | 0.98 |
Live birth rate | 31/106 (29.24) | 25/94 (26.59) | 1.0996 (0.7027-1.7207) | 0.67 |
Miscarriage rate | 10/47 (21.27) | 13/38 (34.21) | 0.6219 (0.3073-1.2585) | 0.18 |
Multiple pregnancy rate | 3/43 (6.97) | 3/38 (7.89) | 0.8837 (0.1895-4.1209) | 0.87 |
Analysis per protocol /ET (n = 184) | Mock (n = 97) | Control (n = 87 ) | Relative risk (95% CI) | P-value |
Clinical pregnancy rate | 43/97 (44.32) | 38/87 (43.67) | 1.0149 (0.7321-1.4069) | 0.92 |
Live birth rate | 31/97 (31.95) | 25/87 (28.73) | 1.1122 (0.7161-1.7273) | 0.47 |
Miscarriage rate | 10/47 (21.27) | 13/38 (34.21) | 0.6219 (0.3073-1.2585) | 0.18 |
Multiple pregnancy rate | 3/43 (6.97) | 3/38 (7.89) | 0.8837 (0.1895-4.1209) | 0.87 |
Data presented as n (%), ITT: Intension to treat, Chi-squared test, P-value 0.05 was considered as significant. Clinical pregnancy: Detection of heart activity on the ultrasound scan; Live birth rate: The percentage of all cycles that lead to live birth (more than 20 wk) |